COL5A2 induced epithelial–mesenchymal transition (EMT) by promoting the expressions of mesenchymal markers (SNAI1, SNAI2, TWIST, VIM, and MMP2), thereby facilitating the malignant phenotypes of GC. The gene discussed is VIM; the disease is gastric cancer.